Biotech Stocks

Afrezza Could Push MannKind Shares Higher, Says 5-Star Analyst

Momentum is picking up for diabetes-focused biotech MannKind (MNKD). Shares surged 36% this week after MannKind’s presentation at the American Diabetes Association’s conference …

3 “Strong Buy” Penny Stocks With Massive Upside Ahead

Penny stocks, you either love them or you hate them. One of the obvious draws of these stocks trading for under $5 per …

Billionaire Israel Englander Bets on These 3 Penny Stocks

Of all the controversial plays on Wall Street, penny stocks take the cake. The risk-tolerant flock to these names as the potential for …

Efgartigimod’s Positive Data Is Good News for Momenta’s Nipocalimab

Biotechs on a tear have been a theme in 2020. Most have taken off on the hope of solving the COVID-19 vaccine or …

3 “Strong Buy” Penny Stocks That Offer Massive Potential Gains

The stock market is heating up, and some Wall Street bulls are turning even more positive. Among those adapting an increasingly bullish approach …

3 “Strong Buy” Biotech Stocks Under $5 With Explosive Upside Potential

Which stocks are leading the pack out on Wall Street? Biotechs.

Is CymaBay’s Seladelpar Back in the Saddle? 5-Star Analyst Weighs In

In the world of biotechs, all it takes is a single piece of good news to change the narrative. This has been exemplified …

MannKind (MNKD) Stock Could Nearly Double in the Next Year, Says Analyst

It has been a rough five years for investors of diabetes-focused biotech MannKind (MNKD). Over the period, shares of the company have declined …

3 Biotech Stocks Under $4 With at Least 50% Upside Potential

It has been almost three months since the coronavirus-driven volatility hit the global economy, and the market continues to rapidly move into both …

Coronavirus Vaccine Could Add Massive Value to This Small-Cap Stock, Says Analyst

COVID-19 vaccine development across the globe is charging ahead with over 120 possible vaccines in progress. Healthcare companies of all sizes have thrown …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts